| SC 13G | 2021-02-16 | Capital World Investors | Cortexyme, Inc. | 2,610,237 | 8.8% | EDGAR |
| SC 13G | 2021-02-16 | Capital International Investors | Cortexyme, Inc. | 2,580,455 | 8.7% | EDGAR |
| SC 13G | 2021-02-16 | Capital International Investors | Cortexyme, Inc. | 2,580,455 | 8.7% | EDGAR |
| SC 13G/A | 2021-02-01 | EPQ LLC, CTYM PS | Cortexyme, Inc. | 936,309 | 3.2% | EDGAR |
| SC 13G/A | 2021-01-29 | TAKEDA PHARMACEUTICAL CO LTD | Cortexyme, Inc. | 87,258 | 0.3% | EDGAR |
| SC 13G/A | 2020-02-14 | Capital Research Global Investors | Cortexyme, Inc. | 2,442,914 | 9.0% | EDGAR |
| SC 13G/A | 2020-02-11 | Lamond David | Cortexyme, Inc. | 1,955,165 | 6.7% | EDGAR |
| SC 13G/A | 2020-01-07 | EPQ LLC, CTYM PS | Cortexyme, Inc. | 936,309 | 3.5% | EDGAR |
| SC 13G | 2019-09-30 | Lamond David | Cortexyme, Inc. | 1,925,165 | 7.2% | EDGAR |
| SC 13G | 2019-09-30 | LAMOND PIERRE | Cortexyme, Inc. | 2,886,530 | 10.8% | EDGAR |
| SC 13G/A | 2019-06-18 | EPQ LLC, CTYM PS | Cortexyme, Inc. | 936,309 | 3.5% | EDGAR |
| SC 13G | 2019-06-10 | EPQ LLC, CTYM PS | Cortexyme, Inc. | 936,309 | 3.5% | EDGAR |
| SC 13G | 2019-05-22 | PFIZER INC | Cortexyme, Inc. | 3,249,973 | 12.2% | EDGAR |
| SC 13G | 2019-05-20 | TAKEDA PHARMACEUTICAL CO LTD | Cortexyme, Inc. | 2,679,802 | 9.9% | EDGAR |